Parmax Pharma Ltd Share Price History
₹ 0.0 Cr
Volume Transacted
(Jan 15, 2025)
0.5 K
Stocks Traded
(Jan 15, 2025)
Last Updated on: Jan 15, 2025
Parmax Pharma Ltd
BSE
15 Jan, 2025
41.28-1.7 (-4.0%)
Prev Close
43.0
Open Price
42.5
Bid Price (QTY)
Offer Price (QTY)
Volume
522
Today's High / Low
42.5 / 40.8
52 WK High / Low
54.0 / 24.2
×
PRICE
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Market Price of Parmax Pharma Ltd
1M
1Y
3Y
5Y
To make informed investment decisions, regularly checking Parmax Pharma Ltd share price can be a beneficial practice. *All values are in Rupees.
Last Ten Days Market Price
| Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
|---|
| 14 Jan 2025 | 43 | 43 | 43.03 | 41.81 |
| 13 Jan 2025 | 40.99 | 41.34 | 44.7 | 40.95 |
| 10 Jan 2025 | 43.1 | 46 | 46 | 42.17 |
| 09 Jan 2025 | 44.38 | 45.14 | 46 | 42.6 |
| 08 Jan 2025 | 44.7 | 42.7 | 44.85 | 42.49 |
| 07 Jan 2025 | 42.72 | 41.81 | 43.9 | 41.81 |
| 06 Jan 2025 | 41.81 | 45.05 | 45.06 | 41 |
| 03 Jan 2025 | 42.92 | 42.71 | 45 | 42.7 |
| 02 Jan 2025 | 43.86 | 45.1 | 46.43 | 42.17 |
| 01 Jan 2025 | 44.22 | 43.37 | 44.24 | 42.04 |
| Date |  Price (₹) |
|---|---|
| 14 Jan 2025 | 43 |
| 13 Jan 2025 | 40.99 |
| 10 Jan 2025 | 43.1 |
| 09 Jan 2025 | 44.38 |
| 08 Jan 2025 | 44.7 |
| 07 Jan 2025 | 42.72 |
| 06 Jan 2025 | 41.81 |
| 03 Jan 2025 | 42.92 |
| 02 Jan 2025 | 43.86 |
| 01 Jan 2025 | 44.22 |
Returns Comparison Table
| Entity | 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|
| Cipla Ltd | -3.3 | -0.0 | -9.5 | -4.5 | 10.3 | 57.2 | 198.9 | 129.4 |
| Dr Reddys Laboratories Ltd | -1.0 | 5.3 | 0.3 | -1.6 | 15.6 | 42.6 | 126.9 | 108.5 |
| Sun Pharmaceuticals Industries Ltd | -4.6 | -2.3 | -7.4 | 11.5 | 33.1 | 105.6 | 296.8 | 115.5 |
| Parmax Pharma Ltd | 0.7 | -11.3 | 13.2 | 12.5 | 31.7 | -30.6 | 127.5 | 244.0 |
| Divis Laboratories Ltd | 1.7 | 2.5 | -3.5 | 31.1 | 53.5 | 30.0 | 220.1 | 605.0 |
| Mankind Pharma Ltd | -8.5 | -0.7 | -3.2 | 24.4 | 22.1 | 0.0 | 0.0 | 0.0 |
| Entity | 1W |
|---|---|
| Cipla Ltd | -3.3 |
| Dr Reddys Laboratories Ltd | -1.0 |
| Sun Pharmaceuticals Industries Ltd | -4.6 |
| Parmax Pharma Ltd | 0.7 |
| Divis Laboratories Ltd | 1.7 |
| Mankind Pharma Ltd | -8.5 |
Last updated time: 15 Jan 15:30 PM
Growth Parameters
| Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Sales (Cr.) | - | 12 | 12 | 21 | 26 | 18 | 15 | 11 |
| Sales YoY Gr. | - | 1190.0% | 0.9% | 74.3% | 25.2% | -30.3% | -15.5% | -28.3% |
| Adj EPS | 0 | 0 | 0.18 | 0.96 | 1.69 | 0.32 | -0.23 | -12.98 |
| YoY Gr. | - | 0.0% | 18.0% | 433.3% | 76.0% | -81.1% | -171.9% | 5543.5% |
| Net Profit (Cr.) | -0 | - | - | - | 1 | - | -0 | -6 |
| BVPS | 10.24 | 10.24 | 10.41 | 11.38 | 13.07 | 13.39 | 13.16 | 0.16 |
| Parameter | 2017 |
|---|---|
| Sales (Cr.) | 0 |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -0 |
| BVPS | 10.24 |
Key Financial Parameters
| Parameter | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|
| Return on Capital Emp. % | 0 | 0.66 | 1.56 | 8.4 | 14.26 | 6.04 | 3.76 | 0 |
| Op. Profit Mgn % | 0 | 9.5 | 9.66 | 8.93 | 13.44 | 14.41 | 14.85 | -30.05 |
| Net Profit Mgn % | 0 | 0 | 0.67 | 2.05 | 2.86 | 0.77 | -0.65 | -52.31 |
| Debt to Equity % | 0.16 | 0.33 | 0.82 | 1.11 | 1.02 | 0.94 | 0.89 | 1.91 |
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | 0 |
| Net Profit Mgn % | 0 |
| Debt to Equity % | 0.16 |
FAQs for Parmax Pharma Ltd Share Price History
What are the key events that typically impact Parmax Pharma Ltd's share price history?
Key events that impact Parmax Pharma Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Parmax Pharma Ltd's share price history?
Stock splits reduce the nominal price of Parmax Pharma Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Parmax Pharma Ltd?
Dividends can influence Parmax Pharma Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Parmax Pharma Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Parmax Pharma Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Parmax Pharma Ltd’s share price history?
To understand Parmax Pharma Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Unlimited trading starting at just Rs. 249*
